Brain and Breast Cancer Cells with PTEN Loss of Function Reveal Enhanced Durotaxis and RHOB Dependent Amoeboid

Annalena Wieland1, Pamela L Strissel1,2,3, Hannah Schorle1

  • 1Laboratory for Molecular Medicine, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuernberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.

Cancers
|October 23, 2021
PubMed
Abstract

Insights

Loss of PTEN in glioblastoma and breast cancer cells enhances brain metastasis. RHOB signaling drives this migration, suggesting RHO-inhibitors as potential therapies for brain tumors.

Area of Science:

  • Oncology
  • Biophysics
  • Cell Biology

Background:

  • Glioblastoma multiforme (GBM) and triple-negative breast cancer (TNBC) with PTEN mutations are linked to poor outcomes and brain metastasis.
  • New therapeutic targets are crucial for managing brain dissemination in these aggressive cancers.

Purpose of the Study:

  • To investigate the signaling pathways controlling brain tumor cell migration dynamics and mechanics.
  • To model brain tumor cell migration using 3D microfibers and scaffolds that mimic brain tissue.

Main Methods:

  • Utilized melt electrowriting to create 3D microfibers and scaffolds.
  • Analyzed GBM and TNBC cell lines with varying PTEN genotypes using RHO-ROCK-PTEN inhibitors and PTEN rescue.
  • Employed live-cell imaging, RNA-sequencing, qPCR, scanning electron microscopy, and confocal microscopy.

Main Results:

  • PTEN-deficient GBM and TNBC cells exhibited increased durotaxis, topotaxis, adhesion, and amoeboid migration on 3D microfibers.
  • These cells showed significantly higher RHOB expression compared to PTEN wildtype cells.
  • RHOB-ROCK-PTEN signaling was confirmed to be essential for these migratory processes.

Conclusions:

  • PTEN genotype and RHOB expression critically influence 3D-dependent cell migration, adhesion, and durotaxis.
  • PTEN-deficient GBM and TNBC cells show an affinity for stiff brain structures, promoting metastasis.
  • 3D microfibers are valuable tools for modeling brain-metastasizing tumor cells, highlighting the therapeutic potential of RHO-inhibitors.